By Andrew Welsh-Huggins
The Associated Press
COLUMBUS, Ohio — Several human rights and anti-death penalty groups have asked the American Pharmacists Association to prohibit members from participating in executions, a request that comes as states increasingly turn to pharmacists for lethal injection drugs.
The groups, which include Amnesty International, the NAACP and the American Civil Liberties Union, are targeting so-called compounded drugs. Such drugs, which are not federally regulated, are individually mixed versions of medications that prison systems are finding increasingly difficult to obtain.
Death penalty opponents say such drugs put inmates at risk of pain and suffering. Two years ago, an outbreak of meningitis that killed 64 and sickened hundreds was traced to a compounding facility in Massachusetts.
Pharmacists who provide compounded drugs are violating key provisions of the pharmacists’ association code of ethics, including helping patients achieve “optimum benefit” from their medications, according to a letter the death penalty opponents presented to the association on Monday.
“Participation in executions undermines the position of trust that pharmacists enjoy in this nation,” said the letter sent ahead of the association’s annual meeting beginning Friday in Orlando, Fla. The letter is part of a lobbying effort spearheaded by the nonprofit group SumOfUs, which says it represents consumers and workers and seeks to “counterbalance the growing power of large corporations.”
Numerous drug makers have put their products off limits for executions, drying up the supply available to prison systems. Missouri has used a compounded version of pentobarbital to execute four inmates with plans for a fifth at midnight today.
Texas has used compounded pentobarbital to execute six inmates, with a seventh execution planned for Thursday.
Lawyers for death row inmates in Oklahoma have alleged the state used compounded pentobarbital to put an inmate to death in January. Michael Wilson’s final words were, “I feel my whole body burning,” and then he didn’t move.
A plan by Georgia to use a similar specialty batch of pentobarbital has been put on hold by a lawsuit challenging the state prison agency’s refusal to identify the compounding pharmacy that provided the drug. The lawsuit also questions the drug’s safety and effectiveness.
In Ohio, the state’s policy calls for the prison system to obtain compounded pentobarbital as a first choice, and then to use a backup method of a sedative and painkiller if the compounded drug can’t be found. The state has chosen the backup method in the past two scheduled executions, although only one was carried out.
The American Medical Association prohibits members from taking action that could cause the death of a condemned inmate, although the association — like the pharmacists’ group — is not a regulatory board with authority over licensing. The American Board of Anesthesiology, however, said anesthesiologists cannot participate in executions if they want board certification.
Breaking news, severe weather alerts, AMBER alerts, sports scores from The Norman Transcript are available as text messages right to your phone or mobile device. You decide which type of alerts you want to receive. Find out more or to signup, click here.